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when vaccine injury claims go to court
throughout the country. The pro-
gram’s four levels of federal re-
view provide a powerful shield 
against large numbers of cases 
reaching state courts. In any cases 
that do reach state courts, it is 
highly unlikely that plaintiffs will 
succeed without additional scien-
tific advancements to support their 
claims. Because state courts must 
deliver judgments based on cred-
ible evidence that satisfies tradi-
tional legal standards, claims re-
lying on evidence similar to that 
presented under the Omnibus Au-
tism Proceeding will have diffi-
culty surviving judicial scrutiny.
The government is committed 
to ensuring that the vaccine supply 
is as safe as the current state of 
scientific knowledge allows. This 
commitment includes oversight of 
all aspects of vaccine development, 
manufacturing, and administra-
tion and promotion of activities 
that ensure that adverse events are 
infrequent. As part of this obliga-
tion, the VICP has perhaps the 
saddest duty — determining which 
persons have truly been harmed 
by vaccines. Consequently, the pro-
gram has adjudicated more than 
7000 cases since its inception, 
yet only 2284 claims have been 
deemed legally eligible for awards, 
totaling $1.8 billion. As Camp-
bell-Smith noted in Hazlehurst, the 
special master’s charge “does not 
permit decision making on the ba-
sis of sentiment but rather re-
quires a careful legal analysis of 
the evidence.”3
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Recently, three special mas-ters of the U.S. Court of Fed-
eral Claims issued carefully rea-
soned, strongly worded opinions 
rejecting claims that medical and 
scientific evidence could demon-
strate causal links between thi-
merosal-containing vaccines or 
measles–mumps–rubella (MMR) 
vaccination and the development 
of chronic health conditions such 
as autism, immune dysfunction, 
and gastrointestinal dysfunction. 
The three cases were test cases 
drawn from more than 5000 sim-
ilar claims filed under the Nation-
al Vaccine Injury Compensation 
Program (VICP), which was estab-
lished in 1988 in response to con-
cerns that injury lawsuits against 
vaccine manufacturers and ad-
ministrators were threatening the 
nation’s childhood-vaccine supply. 
Because the injuries claimed in 
these cases were not listed in the 
VICP’s Vaccine Injury Table, in 
order to receive compensation un-
der the program, the families had 
to demonstrate through medical 
or scientific evidence that it is 
more likely than not that vacci-
nation played a significant role 
in causing such injuries.
In VICP-related proceedings, 
the court has broad authority to 
seek out and consider informa-
tion that might help it resolve 
questions about injury causation. 
Toward this end, the special mas-
ters informed their decisions 
by reviewing an extraordinary 
amount of scientific and medical 
evidence, including the testimo-
ny of 28 medical experts, 50 ex-
pert reports, and more than 5000 
pages of proceedings transcripts 
and briefs that included more 
than 900 scientific articles.
The concern the special mas-
ters felt for the families who 
must cope with the daily chal-
lenges of caring for children with 
devastating chronic illnesses of 
as yet unknown origin is evident 
throughout the more than 600 
pages of legal decisions. Further-
more, the special masters were 
convinced that the parents had 
filed their claims in good faith. 
However, they were far less sym-
pathetic toward both the evidence 
proffered by the claimants and 
the physicians who testified and 
offered research in support of 
the claims. According to Special 
Master George Hastings, writing 
in Cedillo v. Sec’y of HHS, “This 
case . . . is not a close case. The 
overall weight of the evidence is 
overwhelmingly contrary to the peti-
tioners’ causation theories. . . . 
Unfortunately, the Cedillos have 
been misled by physicians who 
are guilty, in my view, of gross 
medical misjudgment” (emphasis 
in the original).1 Absent signifi-
cant and dramatic new scientific 
findings, future litigation attempt-
ing to tie autism to vaccination 
is likely to meet a similar fate. 
However, many challenges for the 
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U.S. childhood immunization pro-
gram remain to be addressed.
The success of the childhood im-
munization program can in part be 
traced to state laws requiring parents 
to provide evidence that their chil-
dren have been vaccinated as a pre-
requisite for enrollment in schools 
and day-care centers. Although state 
authority to implement childhood 
immunization mandates is anchored 
in fundamental constitutional princi-
ples, states’ processes for structuring 
the childhood vaccination program 
are highly politicized. States attempt 
to strike some balance between the 
power to require vaccination and 
consideration for parental beliefs and 
autonomy by allowing for exemptions 
from vaccine requirements. Most 
states permit exemptions on religious 
grounds, and a growing number of 
states permit exemption claims based 
on broader philosophical or personal 
objections. States also have widely 
varied administrative structures for 
approving exemption requests. Not 
surprisingly, states with expansive 
bases for exemption and more limit-
ed administrative requirements for 
fulfilling exemption requests have 
more parents opting out of vaccinat-
ing their children — a trend that in-
creases the likelihood of outbreaks of 
vaccine-preventable diseases2 and 
creates potential geographic “hot 
spots” where high concentrations of 
exempted children may compromise 
community-wide protection. While 
continuing to support the rights of 
parents to choose to refuse vaccina-
tions for their children, states should 
explore strengthening their adminis-
trative process for approving exemp-
tions to ensure that they are limited 
to families with deeply held beliefs.
The benefits of vaccination to the 
child and the public are widely known 
and may be demonstrated with the 
use of scientific data. But parents 
weigh choices about vaccination us-
ing conceptions of risk, benefit, and 
trust that are broader than anything 
that can be demonstrated through 
statistics or biology.3 Trust can be 
enhanced by improving the transpar-
ency of the decision-making process 
for approving and enforcing vaccina-
tion mandates. A failure to ensure 
adequate public participation in this 
process can lead to a potentially 
damaging backlash against such 
public health interventions, as was 
seen in the extremely negative re-
sponse to the decision by the gover-
nor of Texas to circumvent the legis-
lature and issue an executive order 
mandating the vaccination of adoles-
cent girls against the human papillo-
mavirus (HPV), as well as the reac-
tion to the news that the HPV vaccine 
manufacturer was lobbying hard to 
get the shot added to the list of man-
datory immunizations.4 To minimize 
the chances of such backlashes, I 
would also argue that public health 
officials should explore options in 
lieu of mandates to encourage the 
uptake of new vac cinations, such as 
public education campaigns or public 
funding for immunization, and as 
others have, I would encourage states 
to consider limiting mandates to ill-
nesses that can reasonably be tied 
to school attendance.5
Finally, and most important, for 
our childhood immunization pro-
gram to continue to be successful, 
our health care system must offer 
greater support for primary care phy-
sicians who serve as educators for 
patients and advocates for patient 
participation in sound preventive 
care strategies. Although the Inter-
net and the media offer unprece-
dented opportunities for the public 
to become informed (or potentially 
misinformed) about health-related 
topics, parents’ understanding of 
such matters should be fostered 
primarily through dialogue that 
they have with their children’s phy-
sicians as partners in care. Yet the 
U.S. reimbursement system for phy-
sicians undervalues the time and ef-
fort that doctors spend in this ca-
pacity. As a result, physicians and 
parents may feel pressured to forgo 
the opportunity to explore the com-
plex medical, scientific, psychologi-
cal, emotional, and political issues 
raised by childhood immunization, 
and parents may remain skeptical 
about committing to vaccination if 
they leave the office feeling that the 
physician did not take (or have) the 
time to understand their concerns. 
Such impressions and attitudes may 
then be passed along to the chil-
dren themselves — a dynamic that 
raises concerns about the potential 
effect of continued parental distrust 
on future public health–related de-
cisions made by those children. As 
national health care reform efforts 
move forward, policymakers should 
be encouraged to support the re-
structuring of the reimbursement 
system in order to enhance the op-
portunity for physicians to engage 
in preventive care interventions, in-
cluding efforts to educate patients 
and vaccine distribution.
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